Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis
Archana Vijay Gaikwad, Mathew Suji Eapen, Kielan Darcy McAlinden, et al.
Expert Review of Respiratory Medicine (2020) Vol. 14, Iss. 10, pp. 1027-1043
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Therapeutic targets in lung tissue remodelling and fibrosis
Gang Liu, Ashleigh M. Philp, Tamera J. Corte, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107839-107839
Open Access | Times Cited: 175
Resveratrol and endothelial function: A literature review
Negin Parsamanesh, Arghavan Asghari, Saeed Sardari, et al.
Pharmacological Research (2021) Vol. 170, pp. 105725-105725
Closed Access | Times Cited: 137
The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD
Qing Song, Ping Chen, Xiangming Liu
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 87
Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
Chiara Giacomelli, Rebecca Piccarducci, Laura Marchetti, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114812-114812
Open Access | Times Cited: 62
Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?
Mathew Suji Eapen, Wenying Lu, Archana Vijay Gaikwad, et al.
European Respiratory Journal (2020) Vol. 56, Iss. 4, pp. 2003167-2003167
Open Access | Times Cited: 67
The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
Hao Shen, Nu Zhang, Yuqing Liu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 33
Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis
Archana Vijay Gaikwad, Wenying Lu, Surajit Dey, et al.
ERJ Open Research (2023) Vol. 9, Iss. 2, pp. 00487-2022
Open Access | Times Cited: 17
Mangiferin alleviates diabetic pulmonary fibrosis in mice via inhibiting endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis
Tinglv Fu, Guorui Li, Donghang Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 5, pp. 1002-1018
Closed Access | Times Cited: 6
Spatially resolved deconvolution of the fibrotic niche in lung fibrosis
Michael Eyres, Joseph A. Bell, Elizabeth R. Davies, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111230-111230
Open Access | Times Cited: 26
Vascular remodelling in IPF patients and its detrimental effect on lung physiology: potential role of endothelial to mesenchymal transition (EndMT)
Archana Vijay Gaikwad, Wenying Lu, Surajit Dey, et al.
ERJ Open Research (2022), pp. 00571-2021
Open Access | Times Cited: 25
Role of glycosyltransferases in carcinogenesis; growth factor signaling and EMT/MET programs
Motoko Takahashi, Yoshihiro Hasegawa, Kento Maeda, et al.
Glycoconjugate Journal (2022) Vol. 39, Iss. 2, pp. 167-176
Open Access | Times Cited: 24
Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review
Lidan Cui, Tianyi Yuan, Zuomei Zeng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113191-113191
Open Access | Times Cited: 23
Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9
Daniela Adriana Oatis, Erika Simon-Repolski, Cornel Baltă, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8210-8210
Open Access | Times Cited: 23
Endothelial to Mesenchymal Transition in Pulmonary Vascular Diseases
Eunsik Yun, Yunjin Kook, Kyung Hyun Yoo, et al.
Biomedicines (2020) Vol. 8, Iss. 12, pp. 639-639
Open Access | Times Cited: 38
IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis
Javier Milara, Inés Roger, Paula Montero, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Vascular Contribution to Lung Repair and Fibrosis
Nunzia Caporarello, Giovanni Ligresti
American Journal of Respiratory Cell and Molecular Biology (2023) Vol. 69, Iss. 2, pp. 135-146
Open Access | Times Cited: 12
Gastric Cancer Mesenchymal Stem Cells Trigger Endothelial Cell Functional Changes to Promote Cancer Progression
Linjing Cui, Ting Liu, Chao‐Yuan Huang, et al.
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 5, pp. 1285-1298
Closed Access | Times Cited: 4
Autophagy as a Guardian of Vascular Niche Homeostasis
К. В. Дергилев, Alexandre Gureenkov, Yelena Parfyonova
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10097-10097
Open Access | Times Cited: 4
Role of Xuefu Zhuyu decoction in improving pulmonary vascular remodeling by inhibiting endothelial-to-mesenchymal transition
Zuomei Zeng, Xinyue Wang, Hongjuan Wang, et al.
Vascular Pharmacology (2025) Vol. 158, pp. 107467-107467
Closed Access
Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension
Prem Bhattarai, Wenying Lu, Archana Vijay Gaikwad, et al.
ERJ Open Research (2022) Vol. 8, Iss. 4, pp. 00254-2022
Open Access | Times Cited: 17
Origins of pathological myofibroblasts in lung fibrosis: insights from lineage tracing mouse models in the single-cell RNA sequencing era
Méline Homps-Legrand, Bruno Crestani, Arnaud Mailleux
AJP Lung Cellular and Molecular Physiology (2023) Vol. 324, Iss. 6, pp. L737-L746
Closed Access | Times Cited: 10
Hsa_circ_0081065 exacerbates IH-induced EndMT via regulating miR-665/HIF-1α signal axis and HIF-1α nuclear translocation
Shan Jiang, Xiaowei Xing, Ming Hong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT)
Archana Vijay Gaikwad, Mathew Suji Eapen, Surajit Dey, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1160-1160
Open Access | Times Cited: 3
Ailanthone ameliorates pulmonary fibrosis by suppressing JUN-dependent MEOX1 activation
Lixin Zhao, Yuguang Zhu, Hua Tao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3543-3560
Open Access | Times Cited: 3
SGLT2 inhibitors as a potential therapeutic option for pulmonary hypertension: mechanisms and clinical perspectives
Jiang-Shan Tan, Yixiao Wei, Lingtao Chong, et al.
Critical Reviews in Clinical Laboratory Sciences (2024), pp. 1-17
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top